CIK 0001707502 · Non-accelerated filer<br>Smaller reporting company
Solid Biosciences Inc.
Sign in to watch- Ticker
- SLDB
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 900943402
- Phone
- 617-337-4680
- Business address
- 500 RUTHERFORD AVENUE, 3RD FLOOR, CHARLESTOWN, MA, 02129
- Former names
- Solid Biosciences, LLC
- 4 Planned sale CFO & Treasurer sold 3,164 shares at $3.96 ($12,529)
- 4 Planned sale Chief Technology Officer sold 2,688 shares at $3.96 ($10,644)
- 4 Planned sale Chief Operating Officer sold 5,561 shares at $3.96 ($22,022)
- 4 Planned sale President and CEO sold 11,365 shares at $3.96 ($45,005)
- 4 Planned sale Director sold 1,711 shares at $3.96 ($6,776)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Planned sale Director sold 144 shares at $3.11 ($448)
- 4 Open-market sale CFO & Treasurer sold 4,073 shares at $3.89 ($15,849)
- 4 Open-market sale Director sold 1,056 shares at $4.31 ($4,551)
- 4 Option exercise Director acquired 3,255 shares (option exercise)
- 4 Open-market sale Chief Regulatory Officer sold 4,610 shares at $5.60 ($25,822)
- 4 Open-market sale President and CEO sold 11,114 shares at $5.60 ($62,236)
- 4 Open-market sale Chief Operating Officer sold 5,072 shares at $5.60 ($28,396)
- 4 Open-market sale Chief Technology Officer sold 2,777 shares at $5.60 ($15,551)
Page 5 of 20 · 383 filings